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Abstract
Background: Smoking tobacco reduces lung function. African Americans have both lower lung function and decreased
metabolism of tobacco smoke compared to European Americans. African ancestry is also associated with lower pulmonary
function in African Americans. We aimed to determine whether African ancestry modifies the association between smoking
and lung function and its rate of decline in African Americans.
Methodology/Principal Findings: We evaluated a prospective ongoing cohort of 1,281 African Americans participating in
the Health, Aging, and Body Composition (Health ABC) Study initiated in 1997. We also examined an ongoing prospective
cohort initiated in 1985 of 1,223 African Americans in the Coronary Artery Disease in Young Adults (CARDIA) Study.
Pulmonary function and tobacco smoking exposure were measured at baseline and repeatedly over the follow-up period.
Individual genetic ancestry proportions were estimated using ancestry informative markers selected to distinguish
European and West African ancestry. African Americans with a high proportion of African ancestry had lower baseline forced
expiratory volume in one second (FEV1) per pack-year of smoking (25.7 ml FEV1/ smoking pack-year) compared with
smokers with lower African ancestry (24.6 ml in FEV1/ smoking pack-year) (interaction P value = 0.17). Longitudinal analyses
revealed a suggestive interaction between smoking, and African ancestry on the rate of FEV1 decline in Health ABC and
independently replicated in CARDIA.
Conclusions/Significance: African American individuals with a high proportion of African ancestry are at greater risk for
losing lung function while smoking.
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Introduction
Tobacco smoking is the leading cause of preventable deaths in
the United States and is an important contributor to accelerated
lung function decline [1]. While European American individuals
tend to smoke greater numbers of cigarettes when compared with
African American individuals [2,3], African Americans appear to
have greater nicotine intake from tobacco smoke and lower renal
clearance of cotinine [4]. In addition, African Americans have
lower normative lung function when compared with European
Americans [5,6] and African ancestry is associated with lower
pulmonary function [7]. Despite these known disparities in
smoking patterns, pharmacokinetics, and lung function, investiga-
tions of smoking-related diseases have been conducted primarily in
European populations with relatively few studies devoted to other
population groups. Therefore, the extent to which differences in
exposure and susceptibility to tobacco smoke impact racial
differences in lung function decline is unclear [8,9]. This question
may have clinical or public health relevance since African
American individuals may be particularly susceptible to smoking
related diseases such as chronic obstructive lung disease
[8,9,10,11,12].
Strong evidence from recent genome-wide association studies
conducted in European American individuals implicates a genetic
component to reduced lung function [13,14,15,16,17]. Addition-
ally, family-based studies, including a study conducted in adult
African Americans [18], suggest that there is a strong heritable
component to lung function [19]. These heritability estimates
increase among smokers [17], suggesting that the decline in lung
function due to smoking is also genetically determined. Given the
described differences by population, we hypothesized that the
effect of tobacco smoking on lung function differs by genetic
ancestry (i.e., a measure of one’s African and European heritage).
In the present study, we examined African Americans which have,
on average, a mixed ancestry of approximately 80% African
ancestry and 20% European ancestry [20]. We investigated
interactions between African genetic ancestry and tobacco
smoking on forced expiratory volume in one second (FEV1) and
its rate of decline in a large population of African Americans.
Methods
Ethics statement
All participants gave written informed consent. The Institution-
al Review Boards at the University of Pittsburgh, the University of
Tennessee and the University of California, San Francisco
approved the Health ABC protocol. The CARDIA study is
reviewed annually by the Institutional Review Boards at the
University of Alabama Birmingham, Northwestern University
Feinberg School of Medicine, University of Minnesota and Kaiser
Permanente in Oakland. CARDIA participants sign a new
informed consent form at every examination.
Health ABC Study Population
Self-identified European American (N= 1,794) and African
American participants (N=1,281) were enrolled into the ongoing
prospective Health, Aging and Body Composition (Health ABC)
cohort study between April 1997 and June 1998. Subjects were
eligible for participation if they were Medicare recipients, aged
70–79 years, and resided near Pittsburgh, Pennsylvania or
Memphis, Tennessee. Additional eligibility criteria for the Health
ABC Study participants included speaking English, being free
from a life-threatening illness, and willingness to remain in the
study area for $3 years. Persons were excluded if they met any of
the following criteria: a) difficulty with daily living activities,
defined as any difficulty walking a quarter of a mile or any
difficulty walking up 10 steps without resting; b) cognitive
impairment; c) inability to communicate with an interviewer; or
d) treated for cancer within the previous three years. Further
details of the Health ABC study population have been published
elsewhere [21,22].
Interview Data Collection and Pulmonary Function
Assessment
Demographic data and detailed smoking histories were
collected from Health ABC participants using a structured
questionnaire during an extensive home interview conducted
within year one of study enrollment. Smaller versions of the
questionnaire were implemented during subsequent years of the
study. Individuals who reported smoking ,100 cigarettes were
categorized as never smokers and individuals who reported
smoking at least 100 cigarettes during their lifetime (i.e. five or
more packs) were queried about smoking initiation, cessation and
average cigarettes per day. Using this information we categorized
participants as current smokers and former smokers and estimated
the number of smoking pack-years (i.e., [no. cigarettes smoked per
day*no. of years smoked]/20).
Methods employed for assessment of pulmonary function in
Health ABC study participants are described elsewhere in greater
detail [21]. Briefly, three to five spirometry tracings were obtained
from enrolled participants during years 1, 5, 8 and 10 of the study
period. All spirometry results were reviewed and scored for
acceptability and reproducibility by two study staff. Pulmonary
function tests meeting American Thoracic Society (ATS) criteria
for acceptability and reproducibility were included in statistical
analyses. This analysis includes participants who self-identified as
African American and whose pulmonary function testing met the
ATS standards.
Genotyping and Estimation of Genetic Admixture in
Health ABC
Health ABC participants provided a blood sample from which
genomic DNA was extracted and whole genome amplified. A
panel of 1,536 autosomal biallelic ancestry informative markers
was selected for genotyping in Health ABC African Americans.
Markers were selected to distinguish the continental ancestral
populations comprising African Americans [23,24]. The ancestry
informative marker (AIM) panel was developed by selecting SNPs
across the genome with high informativeness for ancestry between
European and African continental populations. Genetic ancestry
informative markers for West African and European ancestry were
genotyped using Illumina technology. Methods for genotyping of
SNPs informative for genetic ancestry, including the quality checks
applied, have been previously described [23,24]. AIMs genotyping
data were also available from West African (N= 104) and
European (N= 241) ancestral populations for improvement of
individual admixture estimation. For estimation of individual
ancestry we included only AIMs found to be in Hardy Weinberg
Equilibrium (HWE) and in linkage equilibrium among the West
African and European ancestral populations [24]. Genetic
ancestry of the African American participants was determined
using a final set of 1,332 AIMs and the software program
STRUCTURE [25] to estimate the proportion of African and
European ancestry in the Health ABC African Americans,
assuming two ancestral populations.
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Independent Replication of Longitudinal Analyses
Coronary Artery Disease in Young Adults (CARDIA) Study
The CARDIA Study is a prospective cohort initiated in 1985,
with 5,115 participants enrolled between the ages of 18 to 30 years
from four clinical sites. Of these, 2,637 self-identified as African
American. Detailed study design, recruitment procedures, and
baseline findings have been previously reported [26,27]. Written
informed consent was obtained for all subjects and IRB approval
was obtained from each participating institution. For this analysis
we included all non-asthmatic African American subjects with
AIMs genotyping data available (N= 1,223). Spirometry was
measured during years 0, 2, 5, 10, and 20 in accordance with ATS
criteria for accuracy and precision [28]. Subject’s data was only
included after age 25 to allow for lung function decline estimation
starting from an age at which plateau lung function is typically
attained. Smoking status was determined by standardized ques-
tionnaire at each visit and individuals were classified as never,
former, or current smokers. Individual African ancestry in the
African American study participants was determined using an
independent panel of 42 biallelic autosomal markers having large
allele frequency differences (delta .0.3) between African and
European populations [29]. As demonstrated by other investiga-
tors, this number of AIMs is sufficient for estimating ancestry
among African Americans [30]. The software program STRUC-
TURE [25] was used to estimate individual admixture proportions
using a K=2 estimate for the number of ancestral subpopulations.
Statistical Analysis
Linear regression models were used to estimate the effect of
African ancestry, coded as a continuous variable, on the
association between tobacco smoke exposure and baseline FEV1
among African Americans without a self-reported diagnosis of
pulmonary disease. Selection of covariates included in regression
models was done using a priori knowledge of variables impacting
pulmonary function resulting in the selection of age, sex, height,
family income, and clinic site as covariates. Continuous variables
were mean centered using measures collected at the time of study
enrollment. Baseline analyses removed observations with stan-
dardized residuals greater than 2.5 (N= 5, indicating few statistical
outliers). Two-way interaction terms between percent African
ancestry and smoking pack-years were included in full linear
regression models to estimate p-values for interactions. Linear
regression models were also stratified by median African ancestry
(80.8%) or smoking status (ever versus never) to assess interactions.
Linear mixed effects models examined the influence of African
ancestry on tobacco smoke exposure and FEV1 decline, adjusting
for the same covariates as in baseline analyses. Restricted
maximum likelihood estimation was implemented to examine
the impact of African ancestry on the association between tobacco
smoke exposure and FEV1 decline while simultaneously account-
ing for the correlation structure between repeated pulmonary
measures over the 10-year follow-up period in Health ABC.
Smoking status was allowed to vary over time and continuous
measures were mean centered. Similar linear mixed effects models
were evaluated in CARDIA examining the relationship between
African ancestry and smoking status (never, current, and former)
on rate of pulmonary function decline. Covariates included sex,
clinic, height, height-squared, body mass index (BMI), smoking
pack-years and maximum attained education. Three-way interac-
tion terms between age (as a measure of time), percent African
ancestry, and smoking status were included in mixed models to
estimate p-values for interactions. A two-sided significance
probability of 0.05 was used to infer presence or absence of
interaction. A p-value of 0.2 indicated suggestive evidence for the
presence or absence of interaction, as a recommended strategy to
reduce type II error and avoid missing a true interaction [31] and
successfully implemented by others [32,33]. Analyses were
performed using SAS, version 9.2 (Cary, North Carolina).
Results
In its initial year, 1,281 African Americans, mean age
73.9 years, were enrolled in the Health ABC study. Repeat
measures of pulmonary function were obtained during years one,
five, eight and ten. At year one 942 African Americans had
acceptable spirometry results and during years five, eight and ten
there were 587, 406, and 337 individuals, respectively, had
acceptable spirometry results; the remaining study individuals
were either lost to follow-up or deceased over the ten year follow-
up period (see Figure S1). Only 160 individuals (12%) reported
having had a physician diagnosis of asthma, chronic obstructive
pulmonary disease, chronic bronchitis, or emphysema at the initial
visit and 77 (48%) of these 160 reported using pulmonary
medications. The majority of African Americans in Health ABC
had at least a high school education (56%) and 49% had a low
income ($10,000–$25,000). Most African American participants
were never smokers (45%), 39% were former smokers and 16%
were current smokers. Mean smoking pack-years was 30 pack-
years with an average of 12 cigarettes smoked per day (Table 1).
Baseline cross-sectional analyses
A total of 813 African Americans had both acceptable quality
spirometry data and individual genetic ancestry estimates.
Multivariable linear regression analyses demonstrated an inverse
relationship between FEV1 and both African ancestry and amount
smoked. Smoking was associated with a lower FEV1 among
individuals with both high African ancestry (defined as greater
than median value of 80.8%) and those with low African ancestry
(less than or equal to 80.8%). The reduction in baseline FEV1
associated with smoking was greater among those with higher
African ancestry. Table 2 illustrates that among smokers only
African Americans with high African ancestry had lower baseline
FEV1 per pack-year smoked (25.7 ml FEV1/ smoking pack-year,
95% confidence interval [CI]: -8.1, -3.3) compared to individuals
with low African ancestry (24.6 ml in FEV1/ smoking pack-year,
95% CI: -7.5, -1.6). This difference was considered suggestive of
an interaction between African ancestry and tobacco smoking
pack-years exposure (P for interaction = 0.17) on baseline FEV1.
Stratifying by smoking status (ever vs. never) also revealed a
greater reduction in lung function with increasing African ancestry
among smokers compared to never smokers (24.4 ml in FEV1
versus 21.4 ml in FEV1), although the interaction between
African ancestry and smoking status was not statistically significant
(Table 3). We also examined FEV1/FVC and did not observe a
significant interaction between African ancestry and smoking (data
not shown).
Longitudinal analyses
Multivariable linear mixed effects models examining the rate of
decline in FEV1 revealed a three-way interaction suggestive of a
complex relationship between age, smoking, and individual
African ancestry in the Health ABC study population, although
results did not meet statistical significance (Table 4: Model 1
P=0.14 for smoking pack-years; Model 2 P=0.16 for former
smokers). A sensitivity analysis removed individuals reporting
pulmonary disease at baseline and found the effect was in the same
direction although no longer statistically significant (P value
.0.20). We applied a similar mixed effects model for FEV1 to the
Ancestry-Smoking Interaction and Lung Function
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CARDIA study population (see Table S1). The numbers and ages
of participants included at each visit are described in Table S2.
We observed a suggestive interaction between age, former
smoking status, and African ancestry (P=0.12) among CARDIA
participants (Table S3) even though this population was signifi-
cantly younger than Health ABC participants. The longitudinal
rate of decline in FEV1 in both Health ABC and CARDIA is
illustrated in Figure 1 (Figure 1A: Health ABC, Figure 1B:
CARDIA). While current smokers with high African ancestry had
lower lung function than current smokers with low African
ancestry, the rates of decline were similar between these two
groups. Former smokers with high African ancestry also had lower
lung function at baseline than former smokers with low African
ancestry. However, in the case of former smokers, the rate of
decline was less in individuals with high African ancestry. Among
those who quit smoking, participants with higher African ancestry
had a slower lung function decline, such that after follow-up,
former smokers had similar lung function regardless of their
proportion of African ancestry. These trends were observed in
both Health ABC and CARDIA participants. We also examined
FEV1/FVC in Health ABC and found a significant interaction
between former smoking status, African ancestry and age
(P=0.02) and a suggestive interaction between smoking pack-
years, African ancestry and age (P=0.12).
Discussion
Using two independent adult cohorts, we demonstrated that
smoking has a greater impact on reduced lung function among
African Americans with high African ancestry than those with low
African ancestry. Importantly, we found smokers with high
African ancestry had lower baseline lung function than individuals
with lower African ancestry. Inclusion of the 1,332 AIMs
separately in models examining the association between tobacco
smoke exposure and baseline FEV1 did not abrogate the response,
even after correcting for multiple testing using false discovery rate
[34], suggesting none of the ancestry informative markers were
responsible for the observed associations. Moreover, baseline
examination of FEV1 among European Americans indicated that
their smoking-associated reduction in lung function was less
(23.9ml FEV1/ smoking pack-year) than in African Americans. It
is well recognized that smoking leads to reduced lung function and
increases the rate of lung function decline with increasing age [35].
Despite this knowledge and established racial/ethnic differences
for pulmonary function, few studies have examined the complex
relationship between race, smoking, and rate of lung function
decline among healthy adults. Using genetic ancestry, we can
elucidate racial/ethnic differences in smoking-related lung func-
tion decline. Genetic ancestry itself is unlikely the cause of these
differences, but may be a proxy for population-specific rare genetic
variants contributing to racial/ethnic differences in lung function
and susceptibility to tobacco smoke [36]. Novel approaches, such
as admixture mapping, may enable us to identify population-
specific variants that contribute to lung function decline [37,38].
Prior to our study, other groups have found inconsistent
associations between race and smoking associated lung function
decline. Vollmer et al. examined racial differences in smoking-
related effects on cross-sectional FEV1 in European American and
African American individuals and found no statistically significant
difference in smoking associated decline [39]. This is distinct from
the findings of others who identified a greater susceptibility to
FEV1 decline per pack-year smoked and a greater susceptibility to
COPD among African American individuals [10,11,40]. Some of
the inconsistencies in prior investigations of racial differences in
smoking-related pulmonary function may be due to their cross-
sectional design [39] or designs which matched on smoking [12],
thereby precluding the ability to examine its impact on racial
differences in pulmonary measures. With statistical approaches
only recently developed for estimating admixture, prior studies
were unable to quantify the degree of African ancestry. Our study
compliments and extends prior investigations comparing African
American and European American individuals by examining
smoking-related changes in lung function in relation to a
continuous measure of African ancestry.
Our findings suggest that tobacco-related lung damage and
African ancestry together have a substantially greater impact on
lung function and perhaps its decline than either factor alone. In
Table 1. Baseline demographic characteristics of 1,281
African Americans participating in the Health ABC study.
Characteristic N (%)
Age, mean years (SD) 73.9 (2.9)
Male sex (%) 552 (43.0)
Education, years (%)
, High school 556 (43.6)
High school
graduate
389 (30.5)
. High school 330 (25.9)
Unknown 6
Income, $ (%)
,10,000 296 (26.2)
10,000–25,000 553 (48.9)
25,001–49,999 225 (19.9)
$ 50,000 56 (5.0)
Unknown 151
Smoking status (%)
Never smokers 573 (44.8)
Current smokers 207 (16.2)
Former smokers 498 (39.0)
Unknown 3
Smoking pack-years{,
mean (SD)
30.3 (25.4)
Age initiated smoking, years,
mean (SD)
19.6 (7.0)
Age stopped smoking, years,
mean (SD)
51.0 (14.0)
Average cigarettes smoked per
day{, mean (SD)
12.4 (8.6)
Pulmonary function,
mean (SD)
FEV1 (milliliters) 1972.2 (575.7)
FVC (milliliters) 2551.8 (724.9)
% African ancestry,
mean (SD)
78.5 (13.1)
Unknown 126
Definition of abbreviations: BMI = body mass index; FEV1 = forced expiratory
volume at one second; FVC = forced vital capacity.
Categorical and continuous variables were assessed with chi-square test and
two-sample t-test, respectively.
{among ever smokers only.
{among current smokers only.
doi:10.1371/journal.pone.0039541.t001
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other words, the relationship between smoking and pulmonary
function depends on the level of African ancestry. Individuals with
high African ancestry are particularly susceptible to the impact of
cigarette smoking on the decline of FEV1. In contrast to current
smokers, former smokers with high African ancestry have lung
function that becomes more similar to individuals with low African
ancestry, suggesting lung function improves with smoking cessation
irrespective of African ancestry. In fact, former smokers with high
African ancestry may have an even greater benefit from smoking
cessation, such that their lung function approaches that of former
smokers with low African ancestry. These findings reveal greater
complexity in the relationship between race and tobacco smoking
associated lung function decline than was seen in an earlier study
[9]. Our findings suggest lung function depends on smoking status
and the proportion of individual African ancestry and highlight the
importance of smoking cessation. Future studies with greater
statistical power are needed to confirm this relationship.
To assess potential survival bias, we compared baseline
characteristics between those lost to follow-up and individuals
remaining in the Health ABC study. Individuals remaining in the
study were more likely to be male, higher BMI, higher education,
fewer smoking pack-years, and lower African ancestry (Table S4)
compared to those lost to follow up during the study period
suggesting survival bias may impact our findings. However, we
found similar associations in the younger CARDIA cohort with a
20-year follow-up and 65% retention for African American
participants, thus supporting the robustness of our findings.
CARDIA participants included in analyses were slightly more
educated and included more females than participants not
included in analyses, but were similar for other key demographic
characteristics (Table S5). The consistency of the associations
showing greater effect sizes in individuals of higher African
ancestry for various measures of smoking suggests that smoking
and African ancestry together may have an important impact on
pulmonary function decline over time. We recognize that this
observation may be due to social, environmental and genetic
factors that co-vary with genetic ancestry. For example, environ-
mental factors which could co-vary with ancestry include
discrimination and proximity to roadways. The reduction in lung
function in those with greatest African ancestry may have occurred
in the distant past due to childhood or adolescent exposure to
tobacco smoke leading to suboptimal lung growth or may be due
to rapid decline in lung function in the early years of smoking.
Health ABC provides a robust approach for observing baseline
spirometry measures, but also allows for assessment of longitudinal
changes in lung function associated with smoking in this unique
population of older African American adults. Replication of our
findings in the CARDIA African American participants provides
additional support. Few studies have ascertained repeated pulmo-
nary function measures in either older populations or African
American individuals. Thus the collection of repeated pulmonary
function measures over a ten year time period in Health ABC and
over 20 years in CARDIA is a notable strength of this study.
Additionally, stringent protocols were implemented to ensure that
quality spirometry measures were obtained. The prospective design
of CARDIA and Health ABC minimizes possible participant
response bias in reporting of smoking exposures.
Table 2. Baseline associations between FEV1 and smoking, stratified by African ancestry, among smokers with quality spirometry
and no pulmonary disease in the Health ABC study.
,80.8% African ancestry $80.8% African ancestry
(N=169) (N=196)
Variable Beta SE P value Beta SE P value
Intercept 2121.67 165.37 ,0.001 2126.33 121.53 ,0.001
Age, years 214.36 12.16 0.24 214.56 9.66 0.13
Female 2383.46 100.53 ,0.001 2375.70 80.60 ,0.001
Smoking, pack-years 24.58 1.50 0.003 25.69 1.21 ,0.001
Standing height, mm 18.72 5.18 ,0.001 21.29 4.32 ,0.001
Household income 57.59 41.77 0.17 9.71 36.71 0.79
Pittsburgh 47.11 72.90 0.52 64.66 57.87 0.27
Definition of abbreviations: SE = standard error; mm = millimeter.
Observations with standardized residuals . 2.5 were removed. Median African ancestry is 80.8%, estimated from 1332 ancestry informative markers.
P value for interaction for percent African ancestry*smoking pack-years = 0.17, estimated from full model.
doi:10.1371/journal.pone.0039541.t002
Table 3. Baseline associations between FEV1 and African
ancestry, stratified by smoking status, among African
Americans with quality spirometry and no pulmonary disease
in the Health ABC study.
Never smokers Ever smokers
(N=270) (N=371)
Variable Beta SE P value Beta SE P value
Intercept 2081.05 212.02 ,0.001 2354.20 190.92 ,0.001
% African ancestry{ 21.43 1.92 0.46 24.40 1.80 0.02
Age, years 219.62 7.85 0.01 213.44 7.75 0.08
Female 2233.20 63.96 ,0.001 2340.9263.98 ,0.001
Standing height,
mm
24.12 3.51 ,0.001 19.21 3.37 ,0.001
Household income 35.19 30.49 0.25 30.46 28.21 0.28
Pittsburgh 95.33 48.29 0.05 30.62 46.15 0.51
Definition of abbreviations: SE = standard error; mm = millimeter.
Observations with standardized residuals .2.5 were removed.
P value for interaction for percent African ancestry*smoking status = 0.38,
estimated from full model.
{African ancestry is coded as a continuous variable.
doi:10.1371/journal.pone.0039541.t003
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In summary, we have demonstrated that African ancestry and
tobacco use act synergistically to accelerate rate of lung function
decline. Specifically, our results suggest that individuals with high
African ancestry have increased risk of smoking-related changes in
lung function and may be an important group for smoking
intervention. In addition, the observation that former smokers
with high African ancestry may have a less rapid rate of decline in
lung function suggests that this group may preferentially benefit
from cessation. Our findings have important public health
implications. We have demonstrated that genetic ancestry may
serve as a biomarker for identifying smokers who would benefit
from targeted counseling regarding smoking cessation [41,42].
One important implication of our findings is that there may be
rare genetic variants relevant to smoking associated lung function
decline that are population-specific and which co-vary with genetic
ancestry [43]. While we cannot rule out that some of these
associations may be in part due to environmental factors which co-
vary with ancestry, these results highlight the scientific advantages
of studying racially mixed populations. Future analyses should
include admixture mapping to identify genomic regions associated
with rate of lung function decline. These regions are likely to
harbor rare population-specific variants that could illuminate
pathogenetic pathways involved in the regulation of tobacco
metabolism and lung function [36]. Reduced lung function is a
predictor of overall morbidity and mortality [44,45]; therefore, it is
imperative to recognize and intervene in the populations at
greatest risk.
Figure 1. Predicted FEV1 decline (in milliliters) by smoking-
ancestry strata derived from a mixed effects model. Health ABC
(A) and CARDIA (B). Current smokers are represented by the m symbol
and former smokers by the N symbol. Low African ancestry groups are
represented by a solid line and high African ancestry by a dashed line.
The groups are as follows: low African current smokers (solid line with
m symbol), high African current smokers (dashed line with m symbol),
low African former smokers (solid line withN symbol), and high African
former smokers (dashed line with N symbol).
doi:10.1371/journal.pone.0039541.g001
Table 4. Longitudinal association between FEV1 rate of
decline, smoking and African ancestry, among African
American participants in the Health ABC study.
FEV1 (ml/yr)
(N=1,737)
Variable Beta SE P value
Model 1{
Intercept 1630.22 58.43 ,0.001
African ancestry, % 22.90 1.40 0.04
Age, year at time t 226.45 10.18 0.01
Smoking, pack-years 24.60 0.79 ,0.001
Age*African*Pack-years 0.007 0.004 0.14
Model 2
Intercept 1629.17 58.66 ,0.001
African ancestry, % 24.37 1.70 0.01
Age, year at time t 231.55 2.24 ,0.001
Smoking, pack-years 24.61 0.77 ,0.001
Age*African*Former
smoker
0.32 0.23 0.16
Age*African*Current
smoker
0.12 0.43 0.78
Mixed effects models are adjusted for sex, standing height, household income,
clinic site and two-way interactions among covariates. Age, height and African
ancestry are mean centered.
{Model 1 is also adjusted for smoking status.
doi:10.1371/journal.pone.0039541.t004
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